UPDATE : Thursday, April 26, 2018
상단여백
Hanmi unveils 3 drug candidates at US cancer conference by Lee Han-soo 2018-04-18 16:49
AstraZeneca up, Novartis down in Q1 outpatient prescriptions by Nam Doo-hyun 2018-04-18 14:58
Roche Korea gets expanded approval for breast cancer drug by Marian Chu 2018-04-18 13:13
Exhibition showcases latest pharma products, trends by Lee Hye-seon 2018-04-17 16:14
Genexine unveils trial results for immunotherapeutic agent by Lee Han-soo 2018-04-17 15:13
라인
How are Korean drugmakers performing in China? by So Jae-hyeon 2018-04-17 15:12
Handok to sell Astellas’ diabetes therapy by Marian Chu 2018-04-17 13:52
GemVax & KAEL gets positive P2 data on GV1001 for prostate hyperplasia by Marian Chu 2018-04-16 16:50
Humedix eyes global entry with skin-regenerating injection by Marian Chu 2018-04-16 14:47
Will anti-smoking drug Champix still be champion? by So Jae-hyeon 2018-04-16 14:46
라인
Janssen Korea launches new psoriasis treatment by Lee Hye-seon 2018-04-16 11:48
GE Healthcare Korea launches ₩2.5-bil. program to foster biotech by Marian Chu 2018-04-16 11:45
Roche Korea’s Alecensa gets approval as 1st line lung cancer therapy by Marian Chu 2018-04-13 16:46
SillaJen reveals clinical results on Pexa-Vec in UK by So Jae-hyeon 2018-04-13 16:38
Hanmi gives up on lung cancer drug Olita by Lee Hye-seon 2018-04-13 11:00
라인
LG Chem works on 3-in-1 combo for hypertension by Lee Hye-seon 2018-04-12 16:32
Obesity drug Saxenda’s sheds ‘1-year effect’ stigma by Nam Doo-hyun 2018-04-11 14:11
YD Life Science preps diabetes complication therapy for global launch by Marian Chu 2018-04-10 17:36
JW Pharm discovers novel H4R antagonist for atopic dermatitis by Marian Chu 2018-04-10 17:36
Janssen Korea gets reimbursement for leukemia drug by Marian Chu 2018-04-10 16:14
여백
여백
여백
Back to Top